Financials
- Market Capitalization 294.6 M
- Employee 92
- Founded 2019
- CEO N/A
- Website www.neumoratx.com
- Headquarter Delaware, United States
- FIGI BBG012W9C4X1
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.23
売上高対価格比率
-592.04
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3354 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.87 USD | +0.26% | -1.78% | +7.20% | -4.91% | 298.72 M USD | ||
| 3355 | INDP Indaptus Therapeutics, Inc. - Common Stock | 2.60 USD | -1.14% | -8.77% | -28.18% | +36.84% | 294.43 M USD | ||
| 3386 | MGNX MacroGenics, Inc. - Common Stock | 4.38 USD | -2.67% | -1.35% | +10.61% | +178.98% | 278.41 M USD | ||
| 3390 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.76 USD | +0.80% | -0.53% | +9.30% | +55.37% | 287.50 M USD |